Despite the fact that Bedaquiline - a medicine used to treat Multidrug-Resistant Tuberculosis (MTR TB) - hurriedly introduced last year with the motive of making India TB-free, it continues to be in trial and is still available only in six centres in the country.
Table of Content:-
According to the World Health Organization report of 2015, 10.4 million contracted tuberculosis and 1.8 million died from the disease. These alarming statistics coupled with the rise of multi-drug resistant tuberculosis are concerning health professionals. Health authorities are highly concerned of the extensively drug-resistant tuberculosis because of the way tuberculosis spreads.
In the latest update regarding tuberculosis, scientists have found success in clinical trials for a possible new vaccine against multi-drug resistant tuberculosis.
A new study found that strains of tuberculosis that bypass most of the drugs that are usually used to treat bacterial infection have been spreading in South Africa, which already has a high tuberculosis infection rate.
Though the efforts of doctors and scientists in working towards eradicating the disease are being applauded, the need for a more accessible scheme that would provide those, especially in the rural population, with sustainable treatment is felt urgent by the public.
How we keep this article up to date:
We work with experts and keep a close eye on the latest in health and wellness. Whenever there is a new research or helpful information, we update our articles with accurate and useful advice.
Current Version